These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19344793)

  • 1. Effects of global or targeted deletion of the EP4 receptor on the response of osteoblasts to prostaglandin in vitro and on bone histomorphometry in aged mice.
    Gao Q; Zhan P; Alander CB; Kream BE; Hao C; Breyer MD; Pilbeam CC; Raisz LG
    Bone; 2009 Jul; 45(1):98-103. PubMed ID: 19344793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to prostaglandin E2 and a selective EP2 receptor agonist.
    Choudhary S; Alander C; Zhan P; Gao Q; Pilbeam C; Raisz L
    Prostaglandins Other Lipid Mediat; 2008 Jun; 86(1-4):35-40. PubMed ID: 18406186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.
    Choudhary S; Blackwell K; Voznesensky O; Deb Roy A; Pilbeam C
    Bone; 2013 Sep; 56(1):31-41. PubMed ID: 23639875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective EP4 receptor antagonist abrogates the stimulation of osteoblast recruitment from bone marrow stromal cells by prostaglandin E2 in vivo and in vitro.
    Shamir D; Keila S; Weinreb M
    Bone; 2004 Jan; 34(1):157-62. PubMed ID: 14751573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins.
    Choudhary S; Halbout P; Alander C; Raisz L; Pilbeam C
    J Bone Miner Res; 2007 Jul; 22(7):1002-10. PubMed ID: 17371157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice.
    Li X; Pilbeam CC; Pan L; Breyer RM; Raisz LG
    Bone; 2002 Apr; 30(4):567-73. PubMed ID: 11934647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype.
    Sakuma Y; Tanaka K; Suda M; Komatsu Y; Yasoda A; Miura M; Ozasa A; Narumiya S; Sugimoto Y; Ichikawa A; Ushikubi F; Nakao K
    Infect Immun; 2000 Dec; 68(12):6819-25. PubMed ID: 11083800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of deletion of the prostaglandin EP4 receptor on stimulation of calcium release from cultured mouse calvariae: impaired responsiveness in heterozygotes.
    Zhan P; Alander C; Kaneko H; Pilbeam CC; Guan Y; Zhang Y; Breyer MD; Raisz LG
    Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):19-26. PubMed ID: 16303601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice.
    Li M; Healy DR; Li Y; Simmons HA; Crawford DT; Ke HZ; Pan LC; Brown TA; Thompson DD
    Bone; 2005 Jul; 37(1):46-54. PubMed ID: 15869929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice.
    Miyaura C; Inada M; Suzawa T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T
    J Biol Chem; 2000 Jun; 275(26):19819-23. PubMed ID: 10749873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anabolic effects of PTH in cyclooxygenase-2 knockout osteoblasts in vitro.
    Choudhary S; Huang H; Raisz L; Pilbeam C
    Biochem Biophys Res Commun; 2008 Aug; 372(4):536-41. PubMed ID: 18501188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.
    Mahalingam CD; Datta T; Patil RV; Kreider J; Bonfil RD; Kirkwood KL; Goldstein SA; Abou-Samra AB; Datta NS
    J Endocrinol; 2011 Nov; 211(2):145-56. PubMed ID: 21852324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide stimulates the production of prostaglandin E2 and the receptor Ep4 in osteoblasts.
    Shoji M; Tanabe N; Mitsui N; Tanaka H; Suzuki N; Takeichi O; Sugaya A; Maeno M
    Life Sci; 2006 Mar; 78(17):2012-8. PubMed ID: 16289620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of mineralized bone nodules by rat calvarial osteoblasts decreases with donor age due to a reduction in signaling through EP(1) subtype of prostaglandin E(2) receptor.
    Fujieda M; Kiriu M; Mizuochi S; Hagiya Ki; Kaneki H; Ide H
    J Cell Biochem; 1999 Nov; 75(2):215-25. PubMed ID: 10502294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 gene disruption promotes proliferation of murine calvarial osteoblasts in vitro.
    Xu Z; Choudhary S; Okada Y; Voznesensky O; Alander C; Raisz L; Pilbeam C
    Bone; 2007 Jul; 41(1):68-76. PubMed ID: 17467356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 receptors EP2 and EP4 are down-regulated in human mononuclear cells after injury.
    Strong VE; Winter J; Yan Z; Smyth GP; Mestre JR; Maddali S; Schaefer PA; Yurt RW; Stapleton PP; Daly JM
    Surgery; 2001 Aug; 130(2):249-55. PubMed ID: 11490357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclo-oxigenase-2 activity does not abolish the anabolic effect of prostaglandin E2 in vivo or in vitro.
    Weinreb M; Kelner A; Keila S
    J Endocrinol; 2002 Jul; 174(1):127-35. PubMed ID: 12098671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro.
    Tomita M; Li X; Okada Y; Woodiel FN; Young RN; Pilbeam CC; Raisz LG
    Bone; 2002 Jan; 30(1):159-63. PubMed ID: 11792579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation.
    Yoshida K; Oida H; Kobayashi T; Maruyama T; Tanaka M; Katayama T; Yamaguchi K; Segi E; Tsuboyama T; Matsushita M; Ito K; Ito Y; Sugimoto Y; Ushikubi F; Ohuchida S; Kondo K; Nakamura T; Narumiya S
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4580-5. PubMed ID: 11917107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of deletion of cyclooxygenase-2, prostaglandin receptor EP2, or EP4 in bone marrow cells on osteoclasts induced by mouse mammary cancer cell lines.
    Ono K; Akatsu T; Kugai N; Pilbeam CC; Raisz LG
    Bone; 2003 Nov; 33(5):798-804. PubMed ID: 14623055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.